Nautilus Biotechnology, Inc. · NASDAQ:NAUT
Nautilus Biotechnology — SPAC Merger (February 2021)
18 slides from Nautilus Biotechnology's SPAC merger presentation, Feb 8, 2021
Slide 1: Town Hall February 8, 2021
Nautilus Biotechnology Confidential – Do Not Distribute Town Hall FEBRUARY 8, 2021
Slide 2: Forward-Looking Statements
Nautilus Biotechnology Confidential – Do Not Distribute 2 Forward-Looking StatementsThis communication contains certain “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended, including statements regard
Slide 3: It's a BIG Day!
3 It’s a BIG Day! Nautilus Biotechnology Confidential – Do Not Distribute
Slide 4: And it's ALL because of YOU!
4 Nautilus Biotechnology Confidential – Do Not Distribute And it’s ALL because of YOU!
Slide 5: Agenda
5 Agenda WHY WE’RE GOING PUBLIC SUJAL SPAC VS A TRADITIONAL IPO SUJAL APPROXIMATE TIMELINE SUJAL WHAT THIS MEANS FOR YOU PARAG & SUJAL COMMUNICATIONS GUIDELINES CHRIS Q&A TEAM Nautilus Biotechnology Confidential – Do Not Distribute
Slide 6: Why We're Going Public
6 Increased visibility and access to capital as a public companyRaising $350M expected to accelerate our development & reduce riskThere are a number of sector-specific tailwinds that have shone a light on companies in our spaceAs a business, we have matured to the point where we believe we can succe
Slide 7: SPAC vs Traditional IPO
7 SPAC vs Traditional IPO We reviewed both optionsSPAC is a Special Purpose Acquisition CompanySPACs are formed for the sole purpose of combining with operating businesses like ours to help accelerate its growthExpected to be a faster, more efficient processAllows Nautilus to expand its partnership
Slide 8: Approximate Timeline
Approximate Timeline 8 MERGER CLOSE (EXACT DATE TBD) SEC FILINGS MARCH FEBRUARY APRIL MAY JUNE ANNOUNCEMENT Nautilus Biotechnology Confidential – Do Not Distribute
Slide 9: What This Means for You
9 Nautilus Biotechnology Confidential – Do Not Distribute What This Means for You
Slide 10: Your Role
No expected executive, team, or reporting structure changes.Our mission, milestones and goals remain the same.Your responsibilities, projects, and initiatives remain the same; continue your focus on execution! 10 Your Role Nautilus Biotechnology Confidential – Do Not Distribute
Slide 11: Compensation & Benefits
11 Compensation & Benefits Base pay and benefits are expected to remain the sameWe will schedule times to discuss employee options in the near futurePlease be patient as we share more details as we are able to in the coming weeksPlease note: shares cannot be traded until the lock up ends, which is 1
Slide 12: Things to Keep in Mind
Nautilus Biotechnology Confidential – Do Not Distribute 12 Things to Keep in Mind Don’t count chickens before they hatch. Stay humble and groundedContinued execution on our plans and milestones mattersComparing stories of other companies can be instructive but also unproductive as we have our own un
Slide 13: Communications Guidelines
13 Nautilus Biotechnology Confidential – Do Not Distribute Communications Guidelines
Slide 14: Why Communication Will Change
Nautilus Biotechnology Confidential – Do Not Distribute 14 We are all becoming investors in a public company!Public companies are governed by SEC regulations and disclosure of material information must be made to all investors at the same time.This means that you (our employees) must be treated as i
Slide 15: Nautilus will continue to act as an independent, private company
Nautilus Biotechnology Confidential – Do Not Distribute 15 Nautilus will continue to act as an independent, private company until the transaction closes.It is critical to avoid talking about Nautilus and its potential transaction outside of those who are aware of the potential transaction internally
Slide 16: Communication Guidelines
Nautilus Biotechnology Confidential – Do Not Distribute 16 Communication Guidelines DO be mindful that the transaction has not closed and, until it does, Nautilus will continue to operate as a private and wholly independent company DON’T talk to the press or investors about the transaction DO remain
Slide 17: Q&A
Nautilus Biotechnology Confidential – Do Not Distribute Q&A
Slide 18: Thank You
Thank You Nautilus Biotechnology Confidential – Do Not Distribute